|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 38/26 | (2006.01) |
| C07K 14/605 | (2006.01) | ||
| A61K 47/54 | (2017.01) | ||
| A61P 3/04 | (2006.01) | ||
| A61P 3/06 | (2006.01) | ||
| A61P 3/10 | (2006.01) |
| (11) | Number of the document | 3727426 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18830618.7 |
| Date of filing the European patent application | 2018-12-14 | |
| (97) | Date of publication of the European application | 2020-10-28 |
| (45) | Date of publication and mention of the grant of the patent | 2025-11-26 |
| (46) | Date of publication of the claims translation | 2026-02-10 |
| (86) | Number | PCT/US2018/065663 |
| Date | 2018-12-14 |
| (87) | Number | WO 2019/125938 |
| Date | 2019-06-27 |
| (30) | Number | Date | Country code |
| 201762608613 P | 2017-12-21 | US |
| (72) |
ALSINA-FERNANDEZ, Jorge , US
COSKUN, Tamer , US
GUO, Lili , US
QU, Hongchang , US
|
| (73) |
Eli Lilly and Company ,
Lilly Corporate Center, Indianapolis, IN 46285,
US
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Inkretino analogai ir jų panaudojimas |
| INCRETIN ANALOGS AND USES THEREOF |
| Payment date | Validity (years) | Amount | |
| 2025-12-10 | 8 | 185.00 EUR |
| 2026-12-14 |